Gut and Tumor Microbiome in Patients With Early Stage (II-III), Locally Advanced or Advanced ER-positive and HER2-negative Breast Cancer.
Clinical trial NCT06126003 · TERMINATED
Trial details
- NCT number
- NCT06126003
- Sponsor
- BioCorteX Inc
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2023-12-01
- Primary completion
- 2024-07-31
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.